BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 8501929)

  • 1. Infusion of autologous platelet rich plasma does not reduce blood loss and product use after coronary artery bypass. A prospective, randomized, blinded study.
    Tobe CE; Vocelka C; Sepulvada R; Gillis B; Nessly M; Verrier ED; Hofer BO
    J Thorac Cardiovasc Surg; 1993 Jun; 105(6):1007-13; discussion 1013-4. PubMed ID: 8501929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial.
    Alvarez JM; Jackson LR; Chatwin C; Smolich JJ
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):457-63. PubMed ID: 11547294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass.
    DelRossi AJ; Cernaianu AC; Vertrees RA; Wacker CJ; Fuller SJ; Cilley JH; Baldino WA
    J Thorac Cardiovasc Surg; 1990 Aug; 100(2):281-6. PubMed ID: 2385125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet function, coagulation tests, and cardiopulmonary bypass: lack of correlation between pre-operative and intra-operative whole blood lumiaggregometry and peri-operative blood loss in patients receiving autologous platelet-rich plasma.
    Irani MS; Izzat NN; Jones JW
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):428-32. PubMed ID: 8589209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass.
    Andreasen JJ; Nielsen C
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):311-7. PubMed ID: 15296889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass.
    Kochamba GS; Pfeffer TA; Sintek CF; Khonsari S
    Ann Thorac Surg; 1996 Mar; 61(3):900-3. PubMed ID: 8619714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding.
    Helm RE; Klemperer JD; Rosengart TK; Gold JP; Peterson P; DeBois W; Altorki NK; Lang S; Thomas S; Isom OW; Krieger KH
    Ann Thorac Surg; 1996 Nov; 62(5):1431-41. PubMed ID: 8893580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations.
    Fish KJ; Sarnquist FH; van Steennis C; Mitchell RS; Hilberman M; Jamieson SW; Linet OI; Miller DC
    J Thorac Cardiovasc Surg; 1986 Mar; 91(3):436-42. PubMed ID: 3512919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plateletpheresis before redo CABG diminishes excessive blood transfusion.
    Christenson JT; Reuse J; Badel P; Simonet F; Schmuziger M
    Ann Thorac Surg; 1996 Nov; 62(5):1373-8; discussion 1378-9. PubMed ID: 8893571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of reinfusion of mediastinal blood drained after coronary surgery on coagulation, fibrinolysis and volume of blood products transfused].
    Szczerkowski P
    Ann Acad Med Stetin; 2003; 49():247-58. PubMed ID: 15552851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting.
    Reichert MG; Robinson AH; Travis JA; Hammon JW; Kon ND; Kincaid EH
    Pharmacotherapy; 2008 Feb; 28(2):151-5. PubMed ID: 18225962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial.
    Murphy GJ; Allen SM; Unsworth-White J; Lewis CT; Dalrymple-Hay MJ
    Ann Thorac Surg; 2004 May; 77(5):1553-9. PubMed ID: 15111142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting.
    Bizzarri F; Scolletta S; Tucci E; Lucidi M; Davoli G; Toscano T; Neri E; Muzzi L; Frati G
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1181-5. PubMed ID: 11726894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of shed mediastinal blood on cardiovascular and pulmonary function: a randomized, double-blind study.
    Boodhwani M; Nathan HJ; Mesana TG; Rubens FD;
    Ann Thorac Surg; 2008 Oct; 86(4):1167-73. PubMed ID: 18805154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bypass grafting with a minimized cardiopulmonary bypass circuit: a prospective, randomized trial.
    Sakwa MP; Emery RW; Shannon FL; Altshuler JM; Mitchell D; Zwada D; Holter AR
    J Thorac Cardiovasc Surg; 2009 Feb; 137(2):481-5. PubMed ID: 19185173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.